Lamotrigine Phase III Study in Bipolar I Disorder

Clinical trial NCT01602510 · COMPLETED

Trial details

NCT number: NCT01602510
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2012-08-01
Primary completion: 2015-12-01
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.